Introduction Cholinesterase inhibitors, along with memantine, are the mainstay of
symptomatic treatment for AD (Alzheimer's disease); however, these medications are …

Microbial exopolysaccharides (EPSs) exhibit diverse functionalities and offer a variety of
structural options that can be altered to fit a specific purpose. EPSs can degrade within the …

A novel pectin-based silver nanocomposite film has been synthesized with the aid of
microwave, using green technology and its capacity to adsorb and deliver anti-Alzheimer's …

Nanocarriers are used to deliver bioactive substances in the treatment of neurodegenerative
diseases such as Alzheimer's disease (AD). These nanocarriers have shown many benefits …

Donepezil hydrochloride containing polyurethane/hydroxypropyl cellulose (PU/HPC)
nanofibers were prepared by the electrospinning for transdermal drug delivery. PU/HPC …

Alongside oral delivery of therapeutics, transdermal delivery systems have gained increased
patient acceptability over past few decades. With increasing popularity, novel techniques …

Donepezil hydrochloride (DPH) was first launched in 1997 as a choline esterase inhibitor
(ChEI). The USFDA has approved it for treatment of Alzheimer's disease since it effectively …

Alzheimer's disease (AD) is a common, progressive, fatal neurodegenerative disorder,
which will play an increasingly important role both socially and financially in the aging …

Transdermal delivery systems are emerging platforms for the delivery of donepezil
hydrochloride (DH) for treating Alzheimer's disease. The primary aim of this study was to …

The main aim of transdermal drug delivery (TDD) is to deliver a specific dose of drug across
the skin and to reach systemic circulation at a controlled rate. On the other hand skin is the …